Navigation Links
PDP Holdings, LLC Announces Support for Health and Human Services Office of Inspector General Guidance
Date:3/29/2013

NASHVILLE, Tenn., March 29, 2013 /PRNewswire/ -- PDP Holdings, LLC (PDP) today announced strong support for the Health and Human Services (HHS) Office of Inspector General (OIG) Special Fraud Alert (SFA) of March 26, 2013.  PDP is an innovative healthcare company with the express mission of lowering healthcare costs, improving outcomes for patients, and empowering doctors and hospitals to deliver better value. This mission is why PDP supports the Special Fraud Alert issued this week.  PDP had the opportunity to meet with OIG officials in 2011 to share details of its business model and positive impact on lowering costs. During that meeting, PDP expressed concerns with the practices of poorly constructed and operated physician owned distributors ("PODs").  Last year, in an article in a leading trade journal, PDP recommended that the OIG use the vehicle of a Special Fraud Alert to issue negative guidance with respect to problematic features of abusive models, given the limitations on other forms of guidance in this area.

"PDP is pleased to see all of the key points we raised with the OIG included in the Special Fraud Alert issued this week," said Tom Gallagher , President and CEO of PDP.  "We welcome the OIG's Special Fraud Alert because it provides more clarity in the marketplace.  The features of 'suspect' PODs listed by the OIG are elements we suggested as being inconsistent with fraud and abuse laws.  The PDP model, in contrast, focuses on increased competition, lowered costs, improved outcomes, and physician-driven case management that improves safety and efficiency."

What the PDP Model Does for the Healthcare System:

  • Increases competition in and access to the medical device marketplace
  • Lowers the cost of purchasing medical devices to local hospitals
  • In
    '/>"/>

SOURCE PDP Holdings, LLC
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. China Pharma Holdings, Inc. Reports First Quarter 2012 Financial Results
2. InfuSystem Holdings, Inc. To Announce First Quarter 2012 Financial Results On May 21, 2012
3. InfuSystem Holdings, Inc. Receives Letter From NYSE MKT Regarding Timely Notice Of Record Date For 2012 Annual Meeting Of Stockholders
4. InfuSystem Holdings, Inc. Reports $14.3 Million of Revenues And $1.6 Million Of EBITDA For The First Quarter Of 2012
5. InfuSystem Holdings, Inc. Terminates "Poison Pill" Plan
6. Hill-Rom Holdings, Inc. Hosts Fiscal 2012 Third Quarter Earnings Conference Call and Webcast
7. RoundTable Healthcare Partners Portfolio Company, Renaissance Acquisition Holdings, LLC Acquires DPT Laboratories
8. Ultra Clean Holdings, Inc. Completes Strategic Merger with Advanced Integration Technologies
9. RoundTable Healthcare Partners Announces Sale of Aspen Surgical Products Holding, Inc. to Hill-Rom Holdings, Inc.
10. Bacterin International Holdings, Inc. Schedules Second Quarter 2012 Financial Earnings Conference Call
11. China Pharma Holdings, Inc. to Report Second Quarter of Fiscal Year 2012 Financial Results on August 15, 2012
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2014)... , Sept. 2, 2014  XBiotech announced ... study being conducted in the US for its ... Human™ monoclonal antibody therapy, is being evaluated in ... complicated with cachexia. The primary endpoint of the ... treated patients to a control population provided only ...
(Date:9/2/2014)... , Sept. 2, 2014 Reportlinker.com announces ... in its catalogue: Acute Heart Failure ... http://www.reportlinker.com/p0689743/Acute-Heart-Failure-Global-Clinical-Trials-Review-H2-2014.html Acute Heart ... Summary GlobalData,s clinical trial report, "Acute ... provides data on the Acute Heart Failure clinical ...
(Date:9/2/2014)... 2014 According to a ... "Latin America Home Healthcare Market (By Device Types: ... Mobility Assist Devices and Medical Supplies; By Services: ... and Unskilled Home Healthcare Services) - Industry Analysis, ... 2020" the Latin American Home Healthcare market was ...
Breaking Medicine Technology:XBiotech Halts Study, Reports Positive Phase III Results with Antibody Therapy for Cancer 2Acute Heart Failure Global Clinical Trials Review, H2, 2014 2Acute Heart Failure Global Clinical Trials Review, H2, 2014 3Acute Heart Failure Global Clinical Trials Review, H2, 2014 4Acute Heart Failure Global Clinical Trials Review, H2, 2014 5Acute Heart Failure Global Clinical Trials Review, H2, 2014 6Acute Heart Failure Global Clinical Trials Review, H2, 2014 7Acute Heart Failure Global Clinical Trials Review, H2, 2014 8Home Healthcare Market in Latin America Expected to Reach USD 17.5 Billion in 2020: Transparency Market Research 2Home Healthcare Market in Latin America Expected to Reach USD 17.5 Billion in 2020: Transparency Market Research 3Home Healthcare Market in Latin America Expected to Reach USD 17.5 Billion in 2020: Transparency Market Research 4Home Healthcare Market in Latin America Expected to Reach USD 17.5 Billion in 2020: Transparency Market Research 5Home Healthcare Market in Latin America Expected to Reach USD 17.5 Billion in 2020: Transparency Market Research 6
... 27 Tengion, Inc. (Nasdaq: TNGN ), ... its first Analyst and Investor Meeting which was held ... and discussions of milestones and key data for the ... archive of the event and presentation materials will be ...
... DEL REY, Calif., Oct. 27 Prostate Oncology Specialists, ... sites in the nation to treat advanced prostate cancer ... therapeutic class known as autologous cellular immunotherapies.  PROVENGE was ... for the treatment of men with asymptomatic or minimally ...
Cached Medicine Technology:Tengion Reviews Pipeline Progress at First Analyst and Investor Meeting; Strategic & Clinical Updates Provided for Regenerative Medicine Programs 2Tengion Reviews Pipeline Progress at First Analyst and Investor Meeting; Strategic & Clinical Updates Provided for Regenerative Medicine Programs 3Tengion Reviews Pipeline Progress at First Analyst and Investor Meeting; Strategic & Clinical Updates Provided for Regenerative Medicine Programs 4Tengion Reviews Pipeline Progress at First Analyst and Investor Meeting; Strategic & Clinical Updates Provided for Regenerative Medicine Programs 5Prostate Oncology Specialists Among First in the Nation to Treat Advanced Prostate Cancer Patients With PROVENGE 2Prostate Oncology Specialists Among First in the Nation to Treat Advanced Prostate Cancer Patients With PROVENGE 3Prostate Oncology Specialists Among First in the Nation to Treat Advanced Prostate Cancer Patients With PROVENGE 4
(Date:9/2/2014)... Angeles, CA (PRWEB) September 02, 2014 ... article on its website titled “Why You Should Wash ... than 80 percent of the global population breathes air ... and particles of pollution lodge in the skin’s pores ... body’s natural barrier to free radicals that may cause ...
(Date:9/2/2014)... groundwork for their own spread throughout the body by ... signals, according to a new report by Johns Hopkins ... Nature Communications , the researchers describe animal and ... molecules released by breast cancer cells. These molecules cause ... nodes to produce proteins called CCL5 and VEGF. CCL5 ...
(Date:9/2/2014)... By Kathleen Doheny ... -- The U.S. obesity epidemic is a driving force behind ... new study. Researchers looked at data from five national ... the increase in diabetes over time could be explained by ... in U.S. adults. The investigators found that the prevalence ...
(Date:9/2/2014)... News) -- A leading group of oncologists has released ... of advanced breast cancer. HER2-negative breast tumors ... the HER2 protein, the American Society of Clinical Oncology ... Almost 80 percent of women with advanced breast cancer ... this guideline, our aim is to improve both the ...
(Date:9/2/2014)... research on sleep apnea, tonsillectomies, hearing loss, head ... be presented in Orlando, FL, September 21-24, at ... the American Academy of OtolaryngologyHead and Neck Surgery ... nose, throat, head and neck physicians in the ... presented were released today, and are available online ...
Breaking Medicine News(10 mins):Health News:Simon Ourian, Kim Kardashian’s Doctor: Air Pollution May Be Aging Your Skin 2Health News:‘Prepped’ by tumor cells, lymphatic cells encourage breast cancer cells to spread 2Health News:Obesity Fueling Rise in Diabetes Rates, Study Finds 2Health News:Obesity Fueling Rise in Diabetes Rates, Study Finds 3Health News:New Guidelines for Treating Form of Advanced Breast Cancer 2
... women with a common thyroid problem may have a ... ,Studies in the past have shown that one of ... Although animal studies found mammary gland cells responded to ... in the relationship between thyroid hormone and breast cancer. ...
... allergen found in the air in many inner-city homes ... in children say researchers. ,According to researchers children ... allergy-causing substance found in mouse urine that is circulating ... developing allergic sensitivity to mice, just as it does ...
... live their lives by their sports drinks and energy drinks ... athletic achievements. //According to a study published in the January ... dental enamel is caused by bottled lemonade, sports drinks and ... enamel by these drinks are as much as 11 times ...
... there are actually scientific reasons why children may be ... strong // sweet tooth. Researchers found variation in a ... and adults. Age and culture also contribute to taste ... the study researchers compared taste sensitivity and food-related behaviors ...
... to evaluate the effect of diseases on contact with children ... were less likely to get the kind of affection other ... HIV-positive parents report avoided certain types of physical contact with ... to their children or pick up infections from the kids ...
... gum disease are more likely to suffer from atherosclerosis, or ... attack // or stroke shows latest research . ... mouths of 657 people who had no history of heart ... used to identify atherosclerosis, was also measured. People with a ...
Cached Medicine News:
...
For the qualitative detection of Wuchereria bancrofti antigen in whole blood, serum and plasma specimens...
For the qualitative detection of Hepatitis B surface Antigen (HBsAG) in human serum, plasma and whole blood specimens...
For the qualitative detection of Hepatitis B surface Antigen (HBsAG) in human serum, plasma and whole blood specimens...
Medicine Products: